Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-C.

Among the 484 patients, the median age at diagnosis was 1.2 years (interquartile range: 0.4-2.2).

Eight (1.7%) patients had metastatic disease at diagnosis, and 273 (56.4%) underwent enucleation.

Overall, 96.1% of patients in the cohort were alive at last follow-up.

The prevalence of grade 3 and 4 complications was 4.8% across the entire cohort (n = 31 events, n = 23 patients).